2008 annual financial data

Marker Therapeutics 2008 Operating margin

Marker Therapeutics 2008 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -1,500,000 USD and net income was -2,196,000 USD.
Operating cash flow was -714,425 USD.

Get free Marker Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
Not available
Operating income
-1,500,000 USD
Net income
-2,196,000 USD
Operating cash flow
-714,425 USD